Stay updated on Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a Study Status section to the Record History page and updated to Revision: v3.4.3 (2026-03-09). The previous revision v3.4.2 (2025-12-26) was deleted.SummaryDifference0.3%

- Check49 days agoChange DetectedThe page history shows Revision: v3.4.2 added and Revision: v3.4.1 removed, indicating a minor update to the history entries rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.1 has been added to the history, and the notices about funding lapse and Revision: v3.4.0 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedA site-wide notice about a lapse in government funding was added, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check70 days agoChange Detected- Show glossary option and color-coded change indicators (green for additions, red for deletions) on the Record History page. A new revision label (Revision: v3.4.0) is displayed to reflect the update.SummaryDifference0.6%

Stay in the know with updates to Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous Prasinezumab in Early Parkinson's Disease Clinical Trial page.